New data on stem cell clinics, INDs, & more including from FDA itself
The International Society for Cell & Gene Therapy or ISCT held a really interesting webinar yesterday on the FDA and unproven stem cell clinics. It was focused on the expiration of the FDA’s discretionary period on unproven stem cell clinics. What will the FDA do now? The webinar included some ideas and also quite a […]
New data on stem cell clinics, INDs, & more including from FDA itself Read More »